Dr. Jack Siemiatycki

Associate Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Jack Siemiatycki. Improve your application with a focused, well-structured draft.

Biography

Jack Siemiatycki is an Associate Professor at the Université de Montréal in the School of Public Health. His research expertise lies in cancer epidemiology and the development of new methods for assessing exposure duration to discover environmental and occupational cancer causes. He has contributed methodological advances for calculating lung cancer cases attributable to smoking in class-action lawsuits, particularly for victims of tobacco exposure. His significant contributions to public health are recognized by his membership in the Canadian Academy of Health Sciences. Siemiatycki has led multiple research projects focusing on occupational exposures and health risks, specifically examining endocrine-disrupting chemicals related to colorectal cancer and the psychosocial effects of environmental changes on maternal-child health. His work encompasses large case-control studies aimed at understanding the implications of industrial exposures on cancer incidence. He is actively involved in supervising graduate students and has mentored numerous theses in his field.

Research Interests

Experience

Associate Professor

2006-01-01 — Present

Université de Montréal • Montreal, QC, Canada

Teaching and conducting research in the area of epidemiology with a focus on occupational and environmental health.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.